Investments
62Portfolio Exits
11Funds
3About Spray Venture Partners
Spray Venture Partners focuses exclusively on investments in emerging healthcare technology companies. Spray Venture Partners prefers to work with clinical and technical founders to create companies that develop, market and deploy innovative technologies to meet major unmet healthcare needs. Per the firm, they prefer to partner with: (1) Clinicians or engineers with a product idea, (2) CEOs looking for early stage venture capital and (3) Healthcare executives interested in joining an exciting early-stage technology company with experienced and helpful investors.
Spray Venture Partners Headquarters Location
2330 Washington Street
Newton, Massachusetts, 02462,
United States
617-332-6060
Expert Collections containing Spray Venture Partners
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find Spray Venture Partners in 1 Expert Collection, including Fitness Tech.
Fitness Tech
227 items
We define fitness tech as companies leveraging software and technology to augment approaches to developing or maintaining physical fitness. Companies in this category develop tools and services including workout apps, wearables, and connected fitness equipment.
Latest Spray Venture Partners News
Oct 9, 2013
Australia's Blue Sky Participates in $12M Conventus Raising Gillian Tan Join Now Sign In Members Only This is the kind of news coverage and analysis you can access exclusively as a WSJ Pro Member. Copyright 2016 Dow Jones & Company, Inc. All Rights Reserved This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.
Spray Venture Partners Investments
62 Investments
Spray Venture Partners has made 62 investments. Their latest investment was in Solace Therapeutics as part of their Series E - II on February 2, 2020.
Spray Venture Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
2/12/2020 | Series E - II | Solace Therapeutics | $6.53M | No | 2 | |
10/11/2018 | Series D - II | Vapotherm | $10M | Yes | 1 | |
12/16/2016 | Series H | Intrinsic Therapeutics | $28.43M | No | 3 | |
9/6/2016 | Series D | |||||
10/29/2015 | Series A - III |
Date | 2/12/2020 | 10/11/2018 | 12/16/2016 | 9/6/2016 | 10/29/2015 |
|---|---|---|---|---|---|
Round | Series E - II | Series D - II | Series H | Series D | Series A - III |
Company | Solace Therapeutics | Vapotherm | Intrinsic Therapeutics | ||
Amount | $6.53M | $10M | $28.43M | ||
New? | No | Yes | No | ||
Co-Investors | |||||
Sources | 2 | 1 | 3 |
Spray Venture Partners Portfolio Exits
11 Portfolio Exits
Spray Venture Partners has 11 portfolio exits. Their latest portfolio exit was Vapotherm on November 14, 2018.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
11/14/2018 | IPO | Public | 5 | ||
9/6/2017 | Acquired | 3 | |||
12/4/2014 | Acquired | 1 | |||
Date | 11/14/2018 | 9/6/2017 | 12/4/2014 | ||
|---|---|---|---|---|---|
Exit | IPO | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | Public | ||||
Sources | 5 | 3 | 1 |
Spray Venture Partners Fund History
3 Fund Histories
Spray Venture Partners has 3 funds, including Spray Venture Fund II LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
3/1/2004 | Spray Venture Fund II LP | Early-Stage Venture Capital | Closed | $72M | 1 |
9/1/1998 | Spray Venture Fund LP | ||||
Spray Venture Fund III LP |
Closing Date | 3/1/2004 | 9/1/1998 | |
|---|---|---|---|
Fund | Spray Venture Fund II LP | Spray Venture Fund LP | Spray Venture Fund III LP |
Fund Type | Early-Stage Venture Capital | ||
Status | Closed | ||
Amount | $72M | ||
Sources | 1 |
Spray Venture Partners Team
4 Team Members
Spray Venture Partners has 4 team members, including current General Partner, Daniel Cole.
Name | Work History | Title | Status |
|---|---|---|---|
Daniel Cole | General Partner | Current | |
Kevin Connors | General Partner | Current | |
Paul F Falvey | Chief Financial Officer | Former | |
Paal Gisholt | General Partner | Former |
Name | Daniel Cole | Kevin Connors | Paul F Falvey | Paal Gisholt |
|---|---|---|---|---|
Work History | ||||
Title | General Partner | General Partner | Chief Financial Officer | General Partner |
Status | Current | Current | Former | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.